WHO ICTRP trial
A phaseII study of nab-paclitaxef in patients with pretreated advanced…
JPRN-UMIN000014202 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000014202 |
|---|---|
| Public title | A phaseII study of nab-paclitaxef in patients with pretreated advanced non-small-cell lung cancer. |
| Scientific title | A phaseII study of nab-paclitaxef in patients with pretreated advanced non-small-cell lung cancer. - A phaseII study of nab-paclitaxef in patients with pretreated advanced non-small-cell lung cancer. |
| Primary sponsor | Kansai Medical University Hirakata Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Non-Small-Cell Lung Cancer |
| Interventions | nab-paclitaxel 100mg/m2 Day1,8,15 Every four weeks |
| Registration date | Sep 6, 2014 |
| Target size | 60 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: